Oncology Flashcards
chemo drugs that cause Myelosuppression
almost all except: asparaginase, bleomycin, vincristine; most monoclonal antibodies and many tyrosine kinase inhibitors.
chemo drugs that cause nausea and vomiting
cisplatin, cyclophosphamide, ifosfamide
chemo drugs that cause mucositis
fluorouracil, capecitabine, irinotecan, methotrexate. many TKIs (afatinib, ponatinib, sorafenib, sunitinib)
chemo drugs that cause diarrhea
fluorouracil, capecitabine, irinotecan
chemo drugs that cause constipation
vincristine, pomalidomide, thalidomide
chemo drugs that cause xerostomia
radiation therapy to head or neck
chemo drugs that cause cardiomyopathy
anthracyclines, HER2 inhibitors (ado-trastuzumab, trastuzumab, pertuzumab), fluorouracil, lapatinib
chemo drugs that cause QT prolongation
arsenic trioxide, many TKIs (dasatinib, nilotinib, vemurafenib, dabrafenib, trametinib, crizotinib, ceritinib, erlotinib, gefitinib, lapatinib, sorafenib, sunitinib) and leuprolide
chemo drugs that cause pulmonary fibrosis
bleomycin, busulfan, carmustice, lomustine
chemo drugs that cause pneumonitis
methotrexate (chronic use), immune therapy MABs (atezolizumab, ipilimumab, nivolumab, pembrolizumab)
chemo drugs that cause hepatotoxicity
antiandorgens (bicalutamide, flutamide, nilutamide), folate antimetabolites (methotrexate, pemetrexed, pralatrexate), pyrimidine analog antimetabolites (cytarabine, gemcitabine), many tyrosine kinase inhibitors, ipilimumab, pembrolizumab, nivolumab, atezolizumab
chemo drugs that cause nephrotoxicity
cisplatin, methotrexate (especially high doses), pemetrexed, pralatrexate, carfilzomib, bevacizumab, nivolumab, pembrolizumab, ipilimumab, atezolizumab
chemo drugs that cause hemorrhagic cystitis
ifosfamide (all doses), cyclophosphamide (higher doses, >1 g /m2)
chemo drugs that cause peripheral sensory neuropathy
vinca alkaloids (vincristine, vinblastine, vinorelbine), platinums (cisplatin, oxaliplatin), taxanes (paclitaxel, docetaxel, cabazitaxel) proteasome inhibitors (bortezomib, carfilzomib), thalidomide, ado-trastuzumab, cytarabine (high doses) brentuzimab
chemo drugs that cause autonomic neuropathy
vinca alkaloids
chemo drugs that cause thromboembolic risk
aromatase inhibitors (e.g. anastrozole, letrozole), SERMs (tamoxifen), immunomodulators (thalidomide, lenalidomide, pomalidomide)
management of chemo-induced myelosuppression
neutropenia: colony-stimulating factors
anemia: RBC transfusions and erythropoiesis-stimulating agents (ESA)
thrombocytopenia: platelet transfusions
management of chemo-induced nausea-vomiting
- neurokinin-1 receptor antagonist (NK1-RA)
- serotonib-3 receptor antagonist (5HT3-RA)
- dexamethasone
- metoclopramide
- prochlorperazine
- IV/PO fluid hydration
management of chemo-induced mucositis
- symptomatic treatment
2. mucosal coating agents, topical local anesthetics
management of chemo-induced diarrhea
- IV/PO fluid hydration
- antimotility agents (e.g. loperamide)
- irinotecan: atropine for early onset diarrhea
management of chemo-induced constipation
- stimulant laxatives
2. polyethylene glycol
management of chemo-induced xerostomia
- artifical saliva substitutes
2. pilocarpine
management of chemo-induced cardiomyopathy
- do not exceed 450-550 mg/m2 for doxorubicin
2. dexrazoxane prophylactically
management of chemo-induced nephrotoxicity
- amifostine (Ethyol) may be given prophylactically)
- ensure adequate hydration
- do not exceed 100 mg/m2/cycle for cisplatin
management of chemo-induced hemorrhagic cystitis
- ifosfamide: mesna (Mesnex)
2. ensure adequate hydration
management of chemo-induced neuropathy
- vincristine: limit dose to 2 mg per week
- oxaliplatin: avoid cold temperature and avoid drinking cold beverages
- bortezomib: SC less neuropathy than IV
what adjucant medication is given with fluorouracil to enhance efficacy as a cofactor
leucovorin or levoleucovorin
what adjucant medication is given with fluorouracil as an antidote
uridine triacetate (Vistogard)
what adjuvant medication is given with methotrexate as an antidote
glucarpidase (Voraxaze)